Biostatistician Abisola Idu, MS, MPH, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.
Ms. Idu began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She has been a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.
Ms. Idu looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.
Efficacy and safety of therapies; association between genetic variability and survival outcomes
Role of nutritional, psychological and lifestyle factors; obesity prevention and control
Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control
Association between social, behavioral and clinical factors and maternal and infant outcomes
Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment
Palazzo L, Dorsey CN, Mogk J, Beatty T, King D, Stefanik-Guizlo K, Key D, Matson TE, Shea M, Caldeiro RM, McWethy AG, Wong ES, Idu AE, Glass JE. Formative evaluation of the implementation of digital therapeutics for opioids and other substance use disorders in primary care (DIGITS Trial). Implement Res Pract. 2024 Dec 12:5:26334895241301670. doi: 10.1177/26334895241301670. eCollection 2024 Jan-Dec. PubMed
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
In a new study, a tool to help discover undiagnosed dementia performed well in 2 separate health systems.
A study led by Dr. Sascha Dublin finds similar outcomes for 3 hypertension medications, filling an evidence gap.
New work by Susan Shortreed, PhD, finds infection risks drive worse outcomes for some racial and ethnic groups.